2 Sources
[1]
PureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED 2.2 billion
PureHealth booked a 53% y-o-y increase in revenue to AED 12.5 billion in H1 2024 following solid growth across its verticals.The Group's EBITDA grew 15% y-o-y to AED 2.2 billion and it recorded a margin of 17.2% in H1 2024. ABU DHABI, UAE, July 31, 2024 /PRNewswire/ -- PureHealth Holding PJSC
[2]
PureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED 2.2 billion By Investing.com
ABU DHABI, UAE, July 31, 2024 /PRNewswire/ -- PureHealth Holding PJSC ('PureHealth' or 'the Group') (ADX Symbol: PUREHEALTH), the largest healthcare platform in the Middle East, today announced its financial results for the period ended 30 June 2024. PureHealth recorded a strong revenue increase of
Share
Copy Link
PureHealth, a leading healthcare platform, announces impressive financial results for the first half of 2024, with a net profit of AED 1.0 billion and EBITDA reaching AED 2.2 billion.

PureHealth, the largest healthcare platform in the Middle East, has reported exceptional financial results for the first half of 2024. The company achieved a net profit of AED 1.0 billion, marking a significant milestone in its growth trajectory
1
. This impressive performance is further underscored by the company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) soaring to AED 2.2 billion2
.The company's revenue for the first half of 2024 stood at AED 5.5 billion, demonstrating strong top-line growth. PureHealth's gross profit margin reached an impressive 31.4%, while its EBITDA margin hit 39.4%
1
. These figures highlight the company's ability to generate substantial profits while maintaining operational efficiency.PureHealth's growth strategy has been bolstered by strategic acquisitions and partnerships. The company completed the acquisition of Circle Health Group, the largest independent hospital operator in the UK, for $1.2 billion in February 2024
2
. This move has significantly expanded PureHealth's international presence and diversified its portfolio.Farhan Malik, Managing Director and Group CEO of PureHealth, expressed satisfaction with the company's performance. He emphasized that the results reflect PureHealth's commitment to operational excellence and its focus on delivering high-quality healthcare services
1
. The company's leadership remains optimistic about future growth prospects, citing ongoing investments in technology and innovation as key drivers.PureHealth's strong financial performance cements its position as a major player in the healthcare sector. The company's success is particularly noteworthy given the challenges faced by the global healthcare industry in recent years. PureHealth's ability to achieve such robust growth demonstrates its resilience and adaptability in a dynamic market environment
2
.Related Stories
A significant factor contributing to PureHealth's success is its investment in cutting-edge healthcare technologies. The company has been at the forefront of implementing AI-driven solutions and digital health platforms, enhancing patient care and operational efficiency
1
. These technological advancements have not only improved healthcare delivery but also contributed to the company's strong financial performance.With the successful acquisition of Circle Health Group, PureHealth is well-positioned for further international expansion. The company's leadership has indicated plans to explore additional growth opportunities in key global markets, leveraging its expertise and financial strength to drive continued success in the healthcare sector
2
.Summarized by
Navi
[1]
1
Technology

2
Technology

3
Policy and Regulation
